JUN 17, 2019 10:25 AM PDT

Russian Scientist Plans to Create More Genetically-edited Humans

WRITTEN BY: Carmen Leitch

After a gene-editing experiment in China last year, an international group of experts pushed back forcefully against the idea that science and the world are ready to edit the genome of human embryos. They suggested a moratorium that would give scientists time to create guidelines and standards for such work. That isn't stopping Russian biologist Denis Rebrikov, who runs an in vitro fertilization clinic and has announced his plans to genetically edit human embryos.

Image credit: Pixabay

The scientists behind the experiment in China, led by researcher He Jiankui, took aim at a gene called CCR5. It's thought that a mutation in this gene can protect people from HIV if they are exposed to the virus. Rebrikov wants to edit the same gene. While a CCR5 mutation may have a protective effect in some instances, there may also be major drawbacks.

Researchers at the University of California, Berkeley, recently showed that mutations in CCR5 could have unforeseen negative impacts, including shortening lifespan. Rebrikov claims that his methodology will be more beneficial and less risky, although exactly how is unclear. The CRISPR/Cas9 system is supposed to target a specific part of the genome, but that specificity isn't perfect - it can potentially also alter parts of the genome that aren't targeted if the target sequences are very similar.

Related: CRISPR Babies May Face Shortened Lifespan

Rebrikov told Science that his "unique" CRISPR system doesn't have the same risk of off-target effects - although he does not offer details in the interview. He already has made an agreement with a clinic that sees HIV patients to find candidate women that want to get pregnant, but don't respond well to drugs used to lessen the likelihood that they will transmit the virus to their pregnancy.

In Rebrikov's interview with Science, the interviewer pointed out that antiretroviral drugs are effective for most HIV-infected people, and there are around one million people infected with HIV in Russia. Therefore, only around thirty HIV-positive Russian women would qualify for this experiment. Rebrikov admitted that his experiment is a proof-of-concept, and that he would be willing to look at other kinds of genetic mutations that result in deafness, blindness or dwarfism. His aim is to try it enough times to apply it more broadly.

Nature contacted several scientists for comment, including Jennifer Doudna, one of the researchers that created the CRISPR/Cas9 gene editing system that's been used in these experiments.

“The technology is not ready,” said Doudna, a University of California Berkeley molecular biologist. “It is not surprising, but it is very disappointing and unsettling.”

Rebrikov will still have to face several Russian regulatory agencies before he proceeds, which will take time. He told Nature it may be as little as one month or as many as three years.

“It is clear that neither scientific self-regulation nor ‘soft law’ are enough to deter scientists willing to defy the worldwide opposition to pursuing reproductive uses of human genome modification,” said Katie Hasson, the Center for Genetics and Society’s Program Director on Genetic Justice.

“It is well past time to initiate meaningful, broadly inclusive, and unrushed discussions of whether heritable genome editing should be permitted,” Hasson added. “In the meantime, we need stronger protections in place to prevent reckless scientists forging ahead without public engagement on a decision with profound consequences for all of us.”

Learn more about the CRISPR/Cas9 gene editing tool from the video above. The video below discusses ethical concerns about the research done on human embryos in China.

Sources: Science, Nature, Center for Genetics and Society

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 12, 2019
Genetics & Genomics
DEC 12, 2019
Gates Foundation and NIH Pledge $200 Million for Gene Therapies in Africa
Over the next four years, the National Institutes of Health and the Bill and Melinda Gates Foundation plan to each invest $100 million towards the developm...
DEC 12, 2019
DEC 12, 2019
A New Strain of HIV is Identified
For the first time since 2000, researchers have identified a new subtype of HIV....
DEC 12, 2019
DEC 12, 2019
Hiccups Key For Infant Brain Development
Although we know how we hiccup, why has remained a mystery for some time, with researchers suggesting it to be an evolutionary hangover from when our ances...
DEC 12, 2019
Genetics & Genomics
DEC 12, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
DEC 12, 2019
Genetics & Genomics
DEC 12, 2019
Promising New Treatment for Mitochondrial Disease Found in Fruit Flies
Researchers at the University of Cambridge have discovered a protein in fruit flies that can reverse the effects of harmful mutations in mitochondrial gene...
DEC 12, 2019
Cell & Molecular Biology
DEC 12, 2019
Scientists Reverse Cognitive Defects in Down Syndrome Mouse Model
Researchers have found a drug that can correct the memory and learning impairments that are linked to Down syndrome....
Loading Comments...